By The TENS Magazine Editorial Staff
Some people reach their 80s and 90s with memory performance comparable to adults decades younger. Researchers call them SuperAgers, and a new human genetics study has narrowed the search for what sets them apart by showing what does not provide a sufficient explanation: the common genetic risk measures most often used in Alzheimer’s disease research.
The peer-reviewed study, published July 23 in Alzheimer’s Research & Therapy, found that the APOE gene and three contemporary Alzheimer’s polygenic-risk scores did not distinguish SuperAgers from cognitively average adults of similar age. The result does not mean genetics is irrelevant. It means the common variants captured by those specific tools did not account for the exceptional memory phenotype in this cohort.
A direct test of a plausible explanation
APOE is the strongest common genetic risk factor associated with late-onset Alzheimer’s disease. Polygenic-risk scores take a wider view by combining information from thousands of genetic variants into an estimate of inherited disease liability. It was reasonable to ask whether SuperAgers simply sit at the low-risk end of those measures.
The research team studied 231 people enrolled through five sites in the United States and Canada: 142 SuperAgers and 89 cognitively average controls. All were at least 80 years old. SuperAgers were classified prospectively using cognitive testing that identified youthful episodic memory, while the controls showed average cognition for their age. The groups had mean ages of 83.7 and 84.7, respectively.
Using DNA extracted from blood, the researchers compared APOE allele and genotype patterns and calculated three Alzheimer’s polygenic-risk scores derived from large genome-wide association studies. Their statistical models adjusted for age, sex, and education. The team also examined whether genetic ancestry changed the associations and reported that the ancestry structure of the two groups substantially overlapped.
What the study found
APOE distributions did not differ significantly between the groups, and none of the three polygenic-risk scores predicted SuperAger status. Accounting for African or non-European ancestry proportions, or for ancestry principal components, did not change that result. An exploratory analysis of 768 genetic variants shared across the scores also found that none remained significant after correction for multiple testing.
The researchers separately screened for a small set of rare variants previously associated with protection from Alzheimer’s disease. One SuperAger carried one such variant, but the analysis did not suggest that the tested protective variants were enriched among SuperAgers. With a cohort of this size, that rare-variant finding is best treated as exploratory rather than definitive.
The University of Chicago Medicine’s research summary frames the central conclusion carefully: exceptional memory in advanced age could not be explained simply by low inherited Alzheimer’s risk as measured here. That distinction matters because avoiding a disease and preserving an unusually high level of function are not necessarily mirror images of the same biology.
Evidence level: human, observational, and cross-sectional
This is direct evidence from human participants, not a mouse, cellular, or computational-only experiment. But it is also a cross-sectional genetic association study, not an intervention and not proof of a mechanism. It did not test a drug, supplement, diet, or behavior, and it did not show that any action can create the SuperAger phenotype, extend lifespan, or improve healthspan.
The negative result has a specific scope. Polygenic-risk scores are generally designed to separate Alzheimer’s cases from controls; they may be less sensitive at distinguishing people at the highest end of memory performance among older adults without dementia. The study also cannot rule out effects from rare variants not captured by the analysis, gene-environment interactions, epigenetic regulation, or many small genetic effects that would require a larger sample to detect.
Important limitations
The authors identify modest statistical power for small genetic effects and limited power for ancestry-specific analyses. Risk scores developed from existing genome-wide datasets may not transfer equally well across ancestries. The cross-sectional design cannot establish which factors came first, and the analysis did not incorporate vascular health, lifestyle, or behavioral measures.
The researchers also did not use Alzheimer’s pathology biomarkers in this analysis. Without measures such as circulating phosphorylated tau or eventual autopsy findings, the study cannot determine whether a participant’s preserved cognition reflects a low burden of disease pathology, resilience despite pathology, or some combination of both. Longitudinal follow-up is needed to connect genetic profiles with cognitive trajectories over time.
Why the boundary is useful
Longevity research often advances by finding a clean boundary around an attractive hypothesis. Here, the boundary is that current common-variant Alzheimer’s risk measures do not adequately explain unusually youthful memory after age 80. That directs attention toward a broader set of possibilities rather than toward a simplistic “good genes” story.
The research initiative is now positioned to combine cognitive testing with brain imaging, blood biomarkers, immune profiling, sleep and activity monitoring, neuropathology, and social and environmental measures. Those layers may help separate resistance to disease from resilience in the presence of disease and from the active maintenance of memory systems.
For now, the responsible conclusion is limited but meaningful: SuperAgers’ exceptional memory was not predicted by APOE or three leading Alzheimer’s polygenic-risk scores in this 231-person cohort. The study does not reveal a recipe for cognitive longevity. It sharpens the question researchers must answer next.
Sources: Piras et al., Alzheimer’s Research & Therapy; University of Chicago Medicine research summary.
Featured image: A senior woman smiles while reading a book at a wooden table in a cabin. Photograph by Shixart1985, via Wikimedia Commons. Source: Own work. Original file: Wikimedia Commons. License: CC BY 2.0. Modifications: None.
